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doi:10.1016/j.jmu.2011.03.002To evaluate the role of three-dimensional power Doppler ultrasonography (3D-PDUS) in differen-
tial diagnosis of soft tissue masses. 93 patients with palpable soft tissue masses (age
range Z 14e88 years; mean age Z 51.3 years, female:male Z 19:74) were scanned with
3D-PDUS. The tumor was traced by the same doctor. The vascularization index (VI), flow index
(FI), and vascularization-flow index (VFI) were calculated automatically. All tumors were proved
by US-guided biopsy or surgical pathology. Wilcoxin Rank Sums test was applied for statistical
analysis. There were 25 benign and 67 malignant tumors. Benign tumors included hematoma
(2), inflammation (3), hemangioma (1), lymphadenitis (2), and schwannoma (4). Malignant tumors
included liposarcoma (2), synovial sarcoma (4), osteosarcoma (3), malignant fibrous histiocytoma
(1), lymphoma (2), and metastasis (6). The VI, FI, and VFI were 4.76  5.83, 32.41  7.8, and
1.76  2.39 in benign tumors, and were 5.28  6.37, 33.08  6.18, and 1.97  2.87 in malignant
tumors, respectively. Therewas no significant difference between benign andmalignant tumor in
VI, FI, and VFI (p > 0.1). The 3D-PDUS could not be used as a single factor to differentiate the
character of soft tissue tumors. Multiparameters in high-resolution ultrasound and color Doppler
ultrasound should be considered.
ª 2011, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.ng-Jen Chiou, Department of Pathology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai
@vghtpe.gov.tw (H.-J. Chiou).
C and the Chinese Taipei Society of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
Table 1. The correlation of the tumor location with
histology in benign soft tissue tumors
Pathology Location
Breast Upper
limb
Lower
limb
Total
Fibroadenoma 6 0 0 6
Chronic inflammation 3 0 0 3
Intraductal papilloma 2 0 0 2
Stromal fibrosis 1 0 0 1
Gynecomastia 1 0 0 1
Phylloides tumor 1 0 0 1
Epithelial hyperplasia 1 0 0 1
Cavernous hemangioma 0 1 0 1
Nodular fasciitis 0 1 0 1
Venous thrombosis 0 1 0 1
Schwannoma 0 2 2 4
Hematoma 0 1 1 2
Lymphadenitis 0 0 2 2
PVNS 0 0 1 1
Epidermal cyst 0 0 1 1
Total 15 6 7 28
PVNS Z pigmented villonodular synovitis.
Table 2. The correlation between the location of soft
tissue tumor and histology in malignant soft tissue tumors
Pathology Location
Breast Upper
limb
Lower
limb
Trunk Total
Carcinoma 45 0 0 0 45
Metastasis 0 2 2 2 6
Synovial sarcoma 0 0 3 1 4
Osteosarcoma 0 0 3 0 3
Lymphoma 0 0 2 0 2
Liposarcoma 0 1 1 0 2
MFH 0 0 1 0 1
Fibrosarcoma 0 0 1 0 1
Rhabdomyosarcoma 0 0 1 0 1
Total 45 3 14 3 65
MFH Z malignant fibrous histiocytoma.
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Soft tissue tumors are not uncommon, and most are benign.
However, the prevalence of malignant soft tissue tumor was
reported around 5.1e15.5% [1,2]. High-resolution ultra-
sound has a high sensitivity for detecting tumors, but it has
not proven to be useful in differentiating benign from
malignant tumors [3e5]. Color Doppler ultrasonography
(CDUS) can depict the presence and morphology of blood
flow in solid tumors [5e8]. Because the reported criteria for
malignancy vary widely, some authors [5e8] question the
usefulness of CDUS in distinguishing benign from malignant
lesions. Doppler spectral analysis can show flow velocity
and resistive index, however low-resistive index could be
seen in both benign and malignant tumors [8,9]. In any
case, power Doppler US (PDUS) is superior to CDUS, espe-
cially in situations of low-velocity blood flow [10e14].
Three-dimensional (3D) US has shown promise in the
obstetric, gynecologic, prostate, and cardiovascular fields
[15e18]. 3D-PDUS also promises in gynecologic field and
neck lymph node differentiation [11,13,14], and was used
to quantify the blood flow and vascularization in adnexa
masses [11]. To our knowledge, no studies focused on the
utility of 3D-PDUS on soft tissue neoplasms. The purpose of
the study was to evaluate the role of 3D-PDUS to differ-
entiate the soft tissue masses, with focusing on the blood
flow and vascularization of the neoplasm.
Materials and Methods
Ninety-three patients (age range Z 14e88 years; mean
age Z 51.3 years) with pathological proof by US-guided
biopsy or surgery were enrolled in this study. They were 74
females and 19 males and were consecutively referred from
orthopedics, plastics, and oncology outpatient department
in our hospital. This study was proved by the institutional
review board of Taipei Veterans General Hospital. All
patients were explained and signed the informed consent.
The procedures were performed by using a 3D US
machine (GE-Kretz Voluson 730 Expert; GE Medical
Systems/Kretztechnik, Zipf, Austria), equipped with a 6- to
12-MHz mechanically driven curved-array transducer.
Volume data acquisition was performed by using a linear
and convex 3D probes. The duration of the scanning
procedure depended on the tumor size. The instrument
settings for scanning angle, pulse repetition frequency,
signal power, wall motion filter, persistence, and color gain
were adjusted at the most sensitive status for every
nodule. All patients were scanned by one experienced
radiologist who was in charge of US for more than 10 years.
The volume data were stored on the hard disk of US
machine and backup to compact disc recordable. The
tumor was traced slice by slice for more than 12 slices by
the same doctor on the US machine. Two senior sonogra-
phers (5 and 10 years experience) were asked to trace 36
nodules to analyze the interobserver agreements.
The vascularization index (VI), flow index (FI), and
vascularization-flow index (VFI) were then calculated
automatically after the tumor tracing was completed, that
is, the VIZ color voxels/(total voxels background voxels),
FI Z weighted color voxels/(color voxels  border voxels),and VFIZweighted color voxels/(total voxels background
voxels) [11e13]. That is, VI represents the density of
vascular signal or the vessels in the tumor. FI represents
a mean color value of all blood flow or intensity of flow at
the time of the three-dimensional sweep. VFI means blood
flow and vascularization [12,13].
Wilcoxin Rank Sums test was used for statistical analysis
that included interobserver reliability test and nonpara-
metric t test.
Results
There were 27 benign and 65 malignant tumors. The loca-
tions of benign tumors included breast (15), upper limb (6),
Fig. 1. The correlation between two (A and B) sonographers’
tracing 18 soft tissue tumors. Vertical axis: data from A
sonographer. Horizontal axis: data from B sonographer.
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upper limb (3), lower limb (14), and the trunk (3). The
histological diagnosis and locations of soft tissue tumors
were presented in Tables 1 and 2. The agreement of tumorFig. 2. An epidermoid cyst in thigh. The tumor was displayed in
coronal view (left lower), and by surface rendering technique (righ
respectively. FI Z flow index; VI Z vascularization index; VFI Z vtracing between two sonographers was high reliability with
intraclass correlation of 0.999 (Fig. 1).
The VI, FI, and VFI were 0.028e19.166 (4.76  5.84),
17.45e47.1 (32.4  7.8), and 0.005e10.04(1.76  2.39) in
benign tumors and 0.045e38.14 (5.28 6.37), 20.37þ 52.39
(33.08  6.18), and 0.009þ 19.98 (1.97 2.87) in malignant
tumors, respectively. There was no significant difference
between benign and malignant tumors in VI, FI, and VFI
(p > 0.1) (Figs. 2e5).
Discussion
CDUS is based on the mean Doppler frequency shift and the
direction of the blood flow. Thus, CDUS has some inherent
limitations, including a tendency of noise to overwhelm the
flow signal if the gain is too high or the Doppler display
threshold too low, Doppler angle dependence, and aliasing
[10]. PDUS is based on the integrated Doppler power
spectrum and indicates the amplitude component of the
received blood flow signals, representing the number of
moving blood cells. PDUS is superior to CDUS in detecting
low-velocity blood flow, especially in detecting alterations
in blood flow [10e12]. This is because PDUS is essentially
angle independent, does not alias, extended dynamic
range, and thus increases machine sensitivity [10e12].
Because of these advantages, PDUS is recommended in
those studies focusing on vessels [10e13].
The disadvantages of two-dimensional (2D) US are oper-
ator dependence, time consuming and inefficient, consid-
erable interobserver variability, limited viewing planes,transverse view (left upper), longitudinal view (right upper),
t lower). The values of VI, FI, and VFI were 10.8%, 36.7, and 4,
ascularization-flow index.
Fig. 3. A schwannoma in upper arm. The tumor was displayed in transverse view (left upper), longitudinal view (right upper),
coronal view (left lower), and by surface rendering technique (right lower). The values of VI, FI, and VFI were 0.21%, 29.36, and
0.06, respectively. FI Z flow index; VI Z vascularization index; VFI Z vascularization-flow index.
Fig. 4. A liposarcoma, myxoid type in elbow. The tumor was displayed in transverse view (left upper), longitudinal view (right
upper), coronal view (left lower), and by surface rendering technique (right lower). The values of VI, FI, and VFI were 0.6%, 34.6,
and 0.2, respectively. FI Z flow index; VI Z vascularization index; VFI Z vascularization-flow index.
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Fig. 5. A synovial sarcoma in popliteal fossa. The tumor was displayed in transverse view (left upper), longitudinal view (right
upper), coronal view (left lower), and by surface rendering technique (right lower). The values of VI, FI, and VFI were 16.5%, 42.2,
and 6.9, respectively. FI Z flow index; VI Z vascularization index; VFI Z vascularization-flow index.
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of time, only a flat anatomic section displayed, and quan-
titative volume estimates on orthogonal images [18]. 3D US
is a more accurate and reproducible method [18].
The four main types of data acquisition techniques of 3D
US include tracked freehand system, untracked freehand
system, mechanical assemblies, and 2D arrays [18]. Tracked
freehand scanning includes acoustic, articulated-arm and
magnetic field tracking of the exact position, and angulation
of the US transducer. To date, the magnetic field tracking is
the most successful. This tracking method minimized elec-
tromagnetic interference and required the shortest distance
between the transmitter and emitter [18]. Instead of
mechanical motion of the first three types, 2D arrays use
electronic scanning and keep stationary. The transducer
emits pyramidal or cylindric US pulses, and generates true
3D information [18]. Untracked freehand system is conve-
nient, but the image quality is operator dependant. The
transducer can be moved or rotated by mechanical assem-
blies at predetermined spatial or angular intervals [18]. In
our study, we scanned all tumors by untracked freehand
system and showed high interobserver agreements.
Some quantification methods for blood flow and vascu-
larization of a lesion had been developed by using PDUS
[11,12]. PDUS with 3D reconstruction [12e14,18] can
provide systemic analysis, in contrast to subjectively select
the most representative slices in 2D images [11]. In our
study, we manually select more than 12 slices of the tumor
by the same doctor on the US machine. This method mimics
3D reconstruction, however because of variable tumor sizes,
it may lead to bias, such as the slice distance different indifferent size of the tumor which could result in scarify
more signal in larger tumor mass.
The application of quantification method VI on cervical
lymph nodes was first described by Wu et al [11]. The VI was
defined as the number of colored pixels within the tumor
section divided by the number of total pixels. That is, VI
may represent the percentage of vascular color signal (or
the vessels) in the tumor block. Then, Pairleitner et al [12]
and Pan et al [13] used the FI and VFI on adnexal masses
and ovarian stroma of variable menstruation status,
respectively. The FI was defined as the color voxels
weighted by the color value (or amplitude) divided by total
color voxels. Thus, the FI may represent a mean color value
(or intensity of flow) of all blood flow in the tumor block at
the time of the three-dimensional sweep. The definition of
VFI was color voxels weighted by the color value (or
amplitude) divided by total voxels. The value of VFI was
equal to the value of VI times FI (VFI Z VI  FI), and thus
may provide the information of both the percentage and
mean value of the color signals in the tumor block [12,13].
Pairleitner et al [12] report the blood flow and vascu-
larization indices, VI, FI, and VFI, show good interobserver
agreement in transvaginal 3D-PDUS for adnexal masses. Our
results for soft tissue neoplasms also show high reliability.
Wu et al [11] report the VI (or vascularity index) is useful
in the differential diagnosis of benign from malignant
cervical lymphadenopathy. No matter what the cutoff
values of VI, the diagnosis accuracy is all around 75%.
However, our results show that the VI, FI, and VFI in either
benign or malignant soft tissue neoplasms are quite diverse,
and show no statistical significance. The controversy may
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advantages over conventional CDUS, it is still a kind of
CDUS. Various parameters of CDUS should be well optimized
for 3D display and quantitative analysis. A change in color
setting may lead to totally different results [13]. This is
a possible reason for statistical insignificance of our results.
The second, our material included a large variety of
diseases, including 45 breast carcinoma and 22 soft tissue
sarcomas in malignant group. Lesion with different
histology and tumor sizes could have different vasculari-
zation and blood flow. It might be impractical to make an
individual index analysis, because of relatively small
number of each histological type. The third, the neo-
angiogenesis in carcinoma and sarcoma may be different.
There are several characters of sarcoma group, including
blurred distinction between stromal and neoplastic
elements, immature blood vessels and tumor cells tend to
invade may also provide vascular channels, much higher
growth rate, and tissue destruction [8]. And finally, some
acute inflammatory processes or vascular lesions are
included in benign group in our study, that is, pigmented
villonodular synovitis, lymphadenitis, nodular fasciitis,
cavenous hemangioma, hematoma, venous thrombosis, and
so forth. These entities may have large peripheral or
feeding vessels with high VI, FI, or VFI, quite different from
other benign soft tissue tumors [5,8].
In conclusion, because of very diverse disease entities
and relative low number of each histology type, our results
show no statistical significance of these quantification
methods of blood flow and vascularization. The clinical
relevance of these new methods in all fields of neoangio-
genesis remains to be determined. The 3D-PDUS could not
be used as a single factor to differentiate the character of
soft tissue tumors. Multiparameters in high-resolution
ultrasound and CDUS should be considered.References
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